608 related articles for article (PubMed ID: 23175513)
1. Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.
Rayment C; Hjermstad MJ; Aass N; Kaasa S; Caraceni A; Strasser F; Heitzer E; Fainsinger R; Bennett MI;
Palliat Med; 2013 Sep; 27(8):714-21. PubMed ID: 23175513
[TBL] [Abstract][Full Text] [Related]
2. Current Status of Malignant Neuropathic Pain in Chinese Patients with Cancer: Report of a Hospital-based Investigation of Prevalence, Etiology, Assessment, and Treatment.
Lu F; Song L; Xie T; Tian J; Fan Y; Liu H
Pain Pract; 2017 Jan; 17(1):88-98. PubMed ID: 26991802
[TBL] [Abstract][Full Text] [Related]
3. Neuropathic pain in children with cancer.
Jacob E
J Pediatr Oncol Nurs; 2004; 21(6):350-7. PubMed ID: 15475472
[TBL] [Abstract][Full Text] [Related]
4. Neuropathic Pain Components in Patients with Cancer: Prevalence, Treatment, and Interference with Daily Activities.
Oosterling A; te Boveldt N; Verhagen C; van der Graaf WT; Van Ham M; Van der Drift M; Vissers K; Engels Y
Pain Pract; 2016 Apr; 16(4):413-21. PubMed ID: 25857631
[TBL] [Abstract][Full Text] [Related]
5. Pain in outpatients treated for breast cancer: prevalence, pharmacological treatment, and impact on quality of life.
Wu HS; Natavio T; Davis JE; Yarandi HN
Cancer Nurs; 2013; 36(3):229-35. PubMed ID: 22964871
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of neuropathic pain in radiotherapy oncology units.
Mañas A; Monroy JL; Ramos AA; Cano C; López-Gómez V; Masramón X; Pérez M;
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):511-20. PubMed ID: 20832183
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of neuropathic pain according to the IASP grading system in patients with chronic non-malignant pain.
Vaegter HB; Andersen PG; Madsen MF; Handberg G; Enggaard TP
Pain Med; 2014 Jan; 15(1):120-7. PubMed ID: 24165161
[TBL] [Abstract][Full Text] [Related]
8. The burden of neuropathic pain: results from a cross-sectional survey.
McDermott AM; Toelle TR; Rowbotham DJ; Schaefer CP; Dukes EM
Eur J Pain; 2006 Feb; 10(2):127-35. PubMed ID: 16310716
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.
Steigerwald I; Müller M; Davies A; Samper D; Sabatowski R; Baron R; Rozenberg S; Szczepanska-Szerej A; Gatti A; Kress HG
Curr Med Res Opin; 2012 Jun; 28(6):911-36. PubMed ID: 22443293
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross-sectional study.
Pérez C; Sánchez-Martínez N; Ballesteros A; Blanco T; Collazo A; González F; Villoria J
Eur J Pain; 2015 Jul; 19(6):752-61. PubMed ID: 25265909
[TBL] [Abstract][Full Text] [Related]
12. Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions.
Gálvez R; Marsal C; Vidal J; Ruiz M; Rejas J
Eur J Pain; 2007 Apr; 11(3):244-55. PubMed ID: 16563819
[TBL] [Abstract][Full Text] [Related]
13. Burden of neuropathic pain in Indian patients attending urban, specialty clinics: results from a cross sectional study.
IndINeP Study Group
Pain Pract; 2008; 8(5):362-78. PubMed ID: 18513226
[TBL] [Abstract][Full Text] [Related]
14. Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial.
Keskinbora K; Pekel AF; Aydinli I
J Pain Symptom Manage; 2007 Aug; 34(2):183-9. PubMed ID: 17604592
[TBL] [Abstract][Full Text] [Related]
15. Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer.
Smith EM; Bakitas MA; Homel P; Piehl M; Kingman L; Fadul CE; Bookbinder M
J Pain Symptom Manage; 2011 Dec; 42(6):822-38. PubMed ID: 21820851
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of painDETECT and S-LANSS in identifying the neuropathic component of mixed pain among patients with tumor-related cancer pain.
Higashibata T; Tagami K; Miura T; Okizaki A; Watanabe YS; Matsumoto Y; Morita T; Kinoshita H
Support Care Cancer; 2020 Jan; 28(1):279-285. PubMed ID: 31041583
[TBL] [Abstract][Full Text] [Related]
17. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
[TBL] [Abstract][Full Text] [Related]
18. Neuropathic pain in cancer patients--prevalence and management in a tertiary care anesthesia-run referral clinic based in urban India.
Bhatnagar S; Mishra S; Roshni S; Gogia V; Khanna S
J Palliat Med; 2010 Jul; 13(7):819-24. PubMed ID: 20636151
[TBL] [Abstract][Full Text] [Related]
19. Neuropathic pain in people with cancer (part 2): pharmacological and non-pharmacological management.
Taverner T
Int J Palliat Nurs; 2015 Aug; 21(8):380-4. PubMed ID: 26312533
[TBL] [Abstract][Full Text] [Related]
20. Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes.
Ong EC
Oncology; 2008; 74 Suppl 1():72-5. PubMed ID: 18758202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
